Ligand validation:3CA3

A2G: 2-acetamido-2-deoxy-alpha-D-galactopyranose

A2G is a Ligand Of Interest in 3CA3 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3CA3_A2G_A_268	90%	54%	0.084	0.966	0.57	1.2	-	1	0	0	100%	0.5
3CA3_A2G_A_267	86%	51%	0.094	0.963	0.75	1.14	-	3	0	0	100%	0.5
3CA6_A2G_A_267	62%	42%	0.118	0.921	0.7	1.54	-	4	0	0	93%	0.7467
5T5P_A2G_b_201	100%	25%	0.036	0.982	1.15	1.89	2	3	0	0	100%	0.9333
2CCV_A2G_A_1101	100%	23%	0.037	0.978	1.67	1.48	3	4	0	0	100%	1
2A2D_A2G_A_459	99%	12%	0.053	0.991	1.08	2.92	1	6	0	0	100%	1
5T5L_A2G_b_201	99%	57%	0.047	0.984	0.74	0.89	-	1	0	0	100%	0.9333
5T5J_A2G_a_201	99%	42%	0.049	0.983	0.94	1.31	-	2	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.